Adjuvant chemotherapy with mFOLFOXIRI versus mFOLFOX6 in MRD-positive stage II-III colorectal cancer

被引：0
|
作者：
Zhang, Jianwei
Hu, Huabin
Cai, Yue
Xie, Xiaoyu
Wu, Zehua
Ling, Jiayu
Chen, Dianke
Liu, Ping
Kang, Liang
Deng, Yanhong
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China
[3] Kunming Med Univ, Affiliated Hosp 3, Kunming, Yunnan, Peoples R China
[4] Sun Yat Sen Univ, Dept Colorectal Surg, Affiliated Hosp 6, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3642
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparison of Hematological Toxicity of mFOLFOX6 vs CAPOX Chemotherapy Regimens in Adjuvant Treatment of Stage II-III Colon Cancer Patients
    Harutyunyan, Lilit
    Arakelyan, Jemma
    Safaryan, Liana
    Avagyan, Armen
    Zohrabyan, Davit
    Sargsyan, Lilit
    Hakobyan, Lusine
    Iskanyan, Samvel
    Papyan, Ruzanna
    Harutyunyan, Martin
    Mkrtchyan, Gohar
    Rushanyan, Marine
    Tamamyan, Gevorg
    Danielyan, Samvel
    Jilavyan, Aram
    Tananyan, Armen
    Bardakhchyan, Samvel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S268 - S268
  • [2] Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer
    Chang, Wenju
    Wei, Ye
    Ren, Li
    Zhong, Yunshi
    Yu, Yiyi
    Chen, Jingwen
    Zhu, Dexiang
    Ye, Lechi
    Qin, Chunzhi
    Zhao, Naiqing
    Niu, Weixin
    Qin, Xinyu
    Xu, Jianmin
    ANNALS OF SURGERY, 2016, 263 (03) : 434 - 439
  • [3] Randomized Controlled Trial of the Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer
    Gogenur, Mikail
    Gogenur, Ismail
    ANNALS OF SURGERY, 2017, 266 (06) : E105 - E106
  • [4] Phase II clinical trial of adjuvant chemotherapy with mFOLFOX6/XELOX for stage III colon cancer in Japanese subjects
    Yamada, T.
    Koda, K.
    Ishibashi, K.
    Kato, H.
    Nishimura, G.
    Ooki, S.
    Yoshimatsu, K.
    Uchida, E.
    Kan, H.
    Kosugi, C.
    Tanaka, S.
    Kato, R.
    Kouketsu, S.
    Nakajima, H.
    Maekawa, H.
    Kobayashi, M.
    Tsubaki, M.
    Yokoyama, M.
    Tanakaya, K.
    Ishida, H.
    ANNALS OF ONCOLOGY, 2015, 26 : 55 - 55
  • [5] Efficacy and safety of mFOLFOX6 with apatinib as postoperative adjuvant chemotherapy in stage IIIB or IIIC colorectal cancer
    Gu, Xiaodong
    Zhou, Minwei
    Wang, Zihao
    Li, Zhenyang
    Yang, Yi
    Zang, Yiwen
    Zhou, Yiming
    Xiang, Jianbin
    Chen, Zongyou
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis
    Ding, Miaomiao
    Zhang, Jianwei
    Hu, Huabin
    Cai, Yue
    Ling, Jiayu
    Wu, Zehua
    Xie, Xiaoyu
    Li, Jianxia
    Li, Weiwei
    Deng, Yanhong
    CLINICAL COLORECTAL CANCER, 2022, 21 (01) : E12 - E20
  • [7] Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
    Yuanyuan Chen
    Mingyue Xu
    Qianwen Ye
    Jia Xiang
    Tianhui Xue
    Tao Yang
    Long Liu
    Bing Yan
    BMC Cancer, 22
  • [8] Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
    Chen, Yuanyuan
    Xu, Mingyue
    Ye, Qianwen
    Xiang, Jia
    Xue, Tianhui
    Yang, Tao
    Liu, Long
    Yan, Bing
    BMC CANCER, 2022, 22 (01)
  • [9] Timing of adjuvant therapy in stage II-III colorectal cancer.
    dos Santos, Lucas Vieira
    Faria, Thaissa Veiga
    Lima, Andre Bacellar Costa
    Abdalla, Kathia Cristina
    Viana, Vivian de Araujo
    Tavares, Isabela R.
    de Moraes, Eduardo Dias
    Melani, Armando
    Cruz, Marcelo Rocha
    Lima, Joao Paulo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Safety of mFOLFOX6/XELOX as adjuvant chemotherapy after curative resection of stage III colon cancer: phase II clinical study (The FACOS study)
    Chihiro Kosugi
    Keiji Koda
    Keiichiro Ishibashi
    Kazuhiko Yoshimatsu
    Soichi Tanaka
    Ryouji Kato
    Hiroyuki Kato
    Masatoshi Oya
    Kazuo Narushima
    Mikito Mori
    Kiyohiko Shuto
    Hideyuki Ishida
    International Journal of Colorectal Disease, 2018, 33 : 809 - 817
12345